Aytu BioScience is trading 9.12% up now at $2.15, after closing at $1.97 on September 16, 2026, with the move appearing aligned with a broader risk-on recovery.
- The S&P 500, Nasdaq Composite, and Dow Jones were up 0.96%, 1.24%, and 0.53%, respectively.
- No verified company-specific catalyst was identified for September 17.
- Aytu BioPharma is scheduled to report fiscal 2026 results after the September 22 close; that upcoming event does not directly explain today’s move.